Effect of whole-body cryotherapy on body balance in patients with multiple sclerosis

• Autorzy: Staszkiewicz Robert , Rusek Stanisław , Lubkowska Anna , Szyguła Zbigniew

Identyfikatory

DOI

10.37190/ABB-02584-2025-02

• Języki publikacji: EN

Abstrakty

EN

Multiple sclerosis (MS) is characterised by multifocal and damage disseminated in time to the central nervous system. This causes various clinical symptoms, including spastically increased muscle tone and balance disorders, which already occur in the early stages of the disease, increasing the frequency of falls, which negatively affects the mobility and independence of patients. Whole-body cryotherapy (WBC) is used in the rehabilitation of MS patients, however, there are no reports on the effect of WBC without subsequent kinesiotherapy on body balance in patients with MS. The aim of the study was to assess the effect of a series of 10 and 20 WBC without kinesiotherapy on the degree of disability assessed by the Expanded Disability Status Scale (EDSS), muscle spasticity evaluated using the Modified Ashworth scale (MAS) and body balance in patients with multiple sclerosis. Methods: The study was completed by 51 patients, aged 23 to 65 years, with a disability grade of 3.5–6.5 on the EDSS scale and spasticity 0–3.0 assessed by the MAS. Patients were randomly assigned to the control group (n = 18) or the experimental group participating in 20 WBC sessions (n = 33). Balance assessment consisted of performing two, 30-second static tests on stabilometric platform, the first test with eyes open and the second one with eyes closed. During these tests, the centre of foot pressure displacement was monitored and analysed in real time. Results: A series of 20 daily WBC resulted in an improvement in the functional status of patients with multiple sclerosis in the form of a significant reduction in EDSS values and spasticity, both on the side with greater and less spasticity. Under the effect of whole-body cryotherapy treatments, there was slight improvement in the stability in patients with multiple sclerosis. Conclusions: Based on the obtained results, it can be concluded that WBC, without subsequent targeted kinesiotherapy, are not sufficient to obtain clear and measurable benefits in the rehabilitation of patients with multiple sclerosis.

Słowa kluczowe

EN

balance disorders; EDSS; spasticity; stabilometric platform; centre of pressure displacement

• Wydawca: Oficyna Wydawnicza Politechniki Wrocławskiej
• Czasopismo: Acta of Bioengineering and Biomechanics
• Rocznik: 2025
• Tom: Vol. 27, no. 1
• Strony: 170--179
• Opis fizyczny: Bibliogr. 55 poz., rys., tab.

Twórcy

autor

Staszkiewicz Robert

• Department of Biomechanics, University of Physical Culture in Krakow, Kraków, Poland.

autor

Rusek Stanisław

• Neurology Department, Ludwik Rydygier Hospital in Krakow, Kraków, Poland.

autor

Lubkowska Anna

• Department of Functional Diagnostics and Physical Medicine Pomeranian Medical University in Szczecin, Szczecin, Poland.

autor

Szyguła Zbigniew

• Department of Sports Medicine and Human Nutrition, University of Physical Culture in Krakow, Kraków, Poland.

Bibliografia

• [1] ALLAN R., MALONE J., ALEXANDER J. et al., Cold for centuries: a brief history of cryotherapies to improve health, injury and post-exercise recovery, Eur. J. Appl. Physiol., 2022, 122 (5), 1153–1162.
• [2] AMATYA B., KHAN F., LA MANTIA L. et al., Non pharmacological interventions for spasticity in multiple sclerosis, Cochrane Database Syst. Rev., 2013, 2:CD009974.
• [3] Atlas of MS 2020. The Multiple Sclerosis International Federation, Atlas of MS, 3rd Ed. The Multiple Sclerosis International Federation (MSIF), September 2020. Copyright © Multiple Sclerosis International Federation (MSIF).
• [4] BARBADO D., GOMEZ-ILLAN R., MORENO-NAVARRO P. et al., Postural control quantification in minimally and moderately impaired persons with multiple sclerosis: The reliability of a posturographic test and its relationships with functional ability, J. Sport Health Sci., 2020, 9 (6), 677–684.
• [5] BLOCK V., PITSCH E., GOPAL A. et al., Identifying falls remotely in people with multiple sclerosis, J. Neurol., 2022, 269, 1889–1898.
• [6] BOHANNON R., SMITH M., Interrater reliability of a modified Ashworth scale of muscle spasticity, Phys. Ther., 1987, 67 (2), 206–207.
• [7] BRYCZKOWSKA I., RADECKA A., KNYSZYNSKA A. et al., Effect of whole body cryotherapy treatments on antioxidant enzyme activity and biochemical parameters in patients with multiple sclerosis, Fam. Med. Prim. Care Rev., 2018, 20 (3), 214–217.
• [8] CAMERON M., HORAK F., HERNDON R. et al., Imbalance in multiple sclerosis: a result of slowed spinal somatosensory conduction, Somatosens. Mot. Res., 2008, 25 (2), 113–122.
• [9] CARPINELLA I., ANASTASI D., GERVASONI E. et al., Balance Impairments in People with Early-Stage Multiple Sclerosis: Boosting the Integration of Instrumented Assessment in Clinical Practice, Sensors (Basel), 2022, 22 (23), 9558.
• [10] COMBER L., PETERSON E., O’MALLEY N. et al., Development of the Better Balance Program for People with Multiple Sclerosis: A Complex Fall-Prevention Intervention, Int. J. MS Care, 2021, 23 (3), 119–127.
• [11] COMBER L., SOSNOFF J., GALVIN R. et al., Postural control deficits in people with Multiple Sclerosis: A systematic review and meta-analysis, Gait Posture, 2018, 61, 445–452.
• [12] COOTE S., COMBER L., QUINN G. et al., Falls in People with Multiple Sclerosis: Risk Identification, Intervention, and Future Directions, Int. J. MS Care., 2020, 22 (6), 247–255.
• [13] FLACHENECKER P., SACCÀ F., VILA C., Variability of Multiple Sclerosis Spasticity Symptoms in Response to THC:CBD Oromucosal Spray: Tracking Cases through Clinical Scales and Video Recordings, Case Rep. Neurol., 2018, 10 (2), 169–176.
• [14] FRITZ N., NEWSOME S., ELOYAN A. et al., Longitudinal relationships among posturography and gait measures in multiple sclerosis, Neurology, 2015, 84 (20), 2048–2056.
• [15] GARCIA C., KARRI J., ZACHARIAS N. et al., Use of Cryotherapy for Managing Chronic Pain: An Evidence-Based Narrative, Pain Ther., 2021, 10 (1), 81–100.
• [16] GOPAL A., GELFAND J., BOVE R. et al., Fall Assessment and Monitoring in People With Multiple Sclerosis: A Practical Evidence-Based Review for Clinicians, Neurol. Clin. Pract., 2023, 13 (5), e200184.
• [17] GREGOROWICZ H., ZAGROBELNY Z., Systemic cryotherapy. Indications and contraindications, process of treatment and its physiological and clinical results, Biomedical Engineering Acta, 2006, 1 (1), 9–20.
• [18] HARB A., KISHNER S., Modified Ashworth Scale, 2023, May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan., PMID: 32119459.
• [19] HOSSEIN-KHANNAZER N., KAZEM ARKI M., KERAMATINIA A. et al., The Role of Low-Level Laser Therapy in the Treatment of Multiple Sclerosis: A Review Study, J. Lasers Med. Sci., 2021, 12, e88.
• [20] HUGOS C., CAMERON M., Assessment and Measurement of Spasticity in MS: State of the Evidence, Curr. Neurol. Neurosci. Rep., 2019, 19 (10), 79.
• [21] INOJOSA H., SCHRIEFER D., KLÖDITZ A. et al., Balance Testing in Multiple Sclerosis-Improving Neurological Assessment with Static Posturography?, Front Neurol., 2020, 11, 135.
• [22] KAHL O., WIERZBICKA E., DEBINSKA M. et al., Compensatory image of the stability of people with multiple sclerosis and atrial vertigo based on posturography examination, Sci. Rep., 2021, 11 (1), 7027.
• [23] KALRON A., NITZANI D., ACHIRON A., Static posturography across the EDSS scale in people with multiple sclerosis: a cross sectional study, BMC Neurol., 2016, 16, 70.
• [24] KURTZKE J., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 1983, 33 (11), 1444–1452.
• [25] LEGRAND F., DUGUE B., COSTELLO J. et al., Evaluating safety risks of whole-body cryotherapy/cryostimulation (WBC): a scoping review from an international consortium, Eur. J. Med. Res., 2023, 28, 387.
• [26] LUBKOWSKA A., Cryotherapy: Physiological Considerations and Applications to Physical Therapy in Perspectives in the 21st Century – Challenges and Possibilities (ed. J. Bettany- -Saltikov), 2012, Rijeka, Croatia.
• [27] LUBKOWSKA A., RADECKA A., KNYSZYNSKA A. et al., Effect of whole-body cryotherapy treatments on the functional state of patients with MS (multiple sclerosis) in a Timed 25-Foot Walk Test and Hand Grip Strength Test, Pomeranian J. Life Sci., 2019, 65 (4), 46–49.
• [28] MATSUDA P., SHUMWAY-COOK A., BAMER A. et al., Falls in multiple sclerosis, PM R, 2011, 3 (7), 624–632.
• [29] MILLER E., KOSTKA J., WLODARCZYK T. et al., Whole-body cryostimulation (cryotherapy) provides benefits for fatigue and functional status in multiple sclerosis patients. A casecontrol study, Acta Neurol. Scand., 2016, 134 (6), 420–426.
• [30] MILLER E., MOREL A., REDLICKA J. et al., Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis, Curr. Neuropharmacol., 2018, 16 (4), 475–483.
• [31] MILLER E., MROWICKA M., MALINOWSKA K. et al., Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients, World J. Biol. Psychiatry, 2011, 12 (3), 223–227.
• [32] MILLER E., NIWALD M., Novel Physiotherapy Approach for Multiple Sclerosis, J. Nov. Physiother., 2014, 4, 4.
• [33] MILLER E., SALUK J., MOREL A. et al., Long-term effects of whole body cryostimulation on uric acid concentration in plasma of secondary progressive multiple sclerosis patients, Scand. J. Clin. Lab. Invest., 2013, 73 (8), 635–640.
• [34] MRAZ M., SKRZEK A., PROSZEWSKA A. et al., Wpływ kompleksowego usprawniania z uwzględnieniem krioterapii ogólnoustrojowej na stan napięcia mięśniowego u chorych na stwardnienie rozsiane, Acta Bio-Optica et Informatica Medica. Inżynieria Biomedyczna 2000, 6 (3–4), 91–95, (in Polish).
• [35] NORBYE A., MIDGARD R., THRANE G., Spasticity, gait, and balance in patients with multiple sclerosis: A cross-sectional study, Physiother. Res. Int., 2020, 25 (1), e1799.
• [36] PAWIK M., KOWALSKA J., RYMASZEWSKA J., The effectiveness of whole-body cryotherapy and physical exercises on the psychological well-being of patients with multiple sclerosis: A comparative analysis, Adv. Clin. Exp. Med., 2019, 28 (11), 1477–1483.
• [37] PÉREZ C., CUASCUT F., HUTTON G., Immunopathogenesis, Diagnosis and Treatment of Multiple Sclerosis: A Clinical Update, Neurol. Clin., 2023, 41 (1), 87–106.
• [38] PETERSON E., CHO C., VON KOCH L. et al., Injurious falls among middle aged and older adults with multiple sclerosis, Arch. Phys. Med. Rehabil., 2008, 89 (6), 1031–1037.
• [39] PETRYŃSKI W., STASZKIEWICZ R., SZYNDERA M., Internal Mechanisms of Human Motor Behaviour: A System-Theoretical Perspective, Front. Psychol., 2022, 13, 841343.
• [40] POLMAN C., REINGOLD S., BANWELL B. et al., Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria, Ann. Neurol., 2011, 69 (2), 292–302.
• [41] PROSPERINI L., CASTELLI L., Spotlight on postural control in patients with multiple sclerosis, Degener. Neurol. Neuromuscul. Dis., 2018, 8, 25–34.
• [42] PROSPERINI L., FORTUNA D., GIANNÌ C. et al., The diagnostic accuracy of static posturography in predicting accidental falls in people with multiple sclerosis, Neurorehabil. Neural. Repair, 2013, 27 (1), 45–52.
• [43] RADECKA A., KNYSZYNSKA A., LUCZAK J. et al., Adaptive changes in muscle activity after cryotherapy treatment: Potential mechanism for improvement the functional state in patients with multiple sclerosis, NeuroRehabilitation, 2021, 48 (1), 119–131.
• [44] REDLICKA J., ZIELINSKA-NOWAK E., LIPERT A. et al., The Relationship between Cognitive Dysfunction and Postural Stability in Multiple Sclerosis, Medicina (Kaunas), 2022, 58 (1), 6.
• [45] RYMASZEWSKA J., LION K., STANCZYKIEWICZ B. et al., The improvement of cognitive deficits after whole-body cryotherapy – A randomised controlled trial, Exp. Gerontol., 2021, 146, 111237.
• [46] SCHWARZ K., SCHMITZ F., Synapse Dysfunctions in Multiple Sclerosis, Int. J. Mol. Sci., 2023, 24, 1639.
• [47] SILVA T., FRAGOSO Y., RODRIGUES M. et al., Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis – Randomized clinical trial, PLoS ONE, 2020, 15 (4), e0230551.
• [48] SIRBU C., THOMPSON D., PLESA F. et al., Neurorehabilitation in Multiple Sclerosis-A Review of Present Approaches and Future Considerations, J. Clin. Med., 2022, 11 (23), 7003.
• [49] SKRZEK A., MRAZ M., GRUSZKA E., Cryotherapy in treatment and rehabilitation process of multiple sclerosis patients, Biomedical Engineering Acta, 2006, 1 (1), 66–69.
• [50] SOYUER F., MIRZA M., ERKORKMAZ U., Balance performance in three forms of multiple sclerosis, Neurol. Res., 2006, 28 (5), 555–562.
• [51] THOMPSON A., BARANZINI S., GEURTS J. et al., Multiple sclerosis, Lancet, 2018, 391 (10130), 1622–1636.
• [52] WALCZAK A., ARKUSZEWSKI M., ADAMCZYK-SOWA M., Rozszerzona Skala Niepełnosprawności (EDSS, Expanded Disability Status Scale) – według J. Kurtzkego, Pol. Przegl. Neurol., 2017, 13 (1), 32–35, (in Polish).
• [53] WESTERLUND T., OKSA J., SMOLANDER J. et al., Neuromuscular adaptation after repeated exposure to whole-body cryotherapy (−110 C), Journal of Thermal Biology, 2009, 34 (5), 226–231.
• [54] ZAHOOR I., GIRI S., Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis, Clin. Rev. Allergy Immunol., 2021, 60 (2), 147–163.
• [55] ZIELIŃSKA-NOWAK E., WŁODARCZYK L., KOSTKA J. et al., New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis, J. Clin. Med., 2020, 9 (11), 3592.